Clinical Trial Update: Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating immunotherapy for neurological post-acute sequelae of SARS-CoV-2 infection, targeting inflammatory processes with enrollm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurological Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Systemic Inflammation, Neuroinflammation | Phase 2 | Status: ENROLLING_BY_INVITATION